Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 2005;46:463-468
Published online before print August 15, 2005, doi: 10.1161/01.HYP.0000178189.68229.8a
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
46/3/463    most recent
01.HYP.0000178189.68229.8av1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rettig, R.
Right arrow Articles by Grisk, O.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rettig, R.
Right arrow Articles by Grisk, O.
Related Collections
Right arrow Animal models of human disease
Right arrow Other etiology

(Hypertension. 2005;46:463.)
© 2005 American Heart Association, Inc.


Brief Reviews

The Kidney as a Determinant of Genetic Hypertension

Evidence From Renal Transplantation Studies

Rainer Rettig; Olaf Grisk

From the Department of Physiology, University of Greifswald, Germany.

Correspondence to Rainer Rettig, MD, Department of Physiology, University of Greifswald, Greifswalder Strasse 11c, D-17495 Karlsburg, Germany. E-mail rettig@uni-greifswald.de


An extract of the first 250 words of the full text is provided, because this article has no abstract.
 


*    Introduction
 
Several lines of evidence suggest that the kidney plays an important role in the genesis of primary hypertension in humans and genetic hypertension in animals. Perhaps the most compelling evidence derives from clinical1–4 and experimental renal transplantation studies,5– 36 which have been performed over the last 3 decades. In virtually all of these studies, the genetic background of the donor kidney had a major impact on long-term blood pressure in the recipients. More specifically, renal grafts from genetically hypertensive donors increased blood pressure in genetically normotensive recipients, whereas renal grafts from genetically normotensive donors lowered blood pressure in genetically hypertensive recipients. In many but not all of the studies, blood pressure traveled with the kidney in both directions.

Although these data clearly show that the kidney is an important determinant of long-term blood pressure in normotension and primary or genetic hypertension, several major problems still remain unresolved. These problems relate mainly to the interpretation of the data and to the potential mechanisms by which the kidney sets the level of long-term blood pressure. In this brief review, we discuss the results and implications of clinical and experimental renal transplantation studies in primary hypertension in humans and genetic hypertension in animals that have been published to date.


*    Clinical Renal Transplantation Studies in Primary Hypertension
 
In the mid-1980s, 3 studies1,2,4 on renal transplant patients were published that supported a major role for the kidney in human essential hypertension. The classical study by Curtis et al1 demonstrated the sustained remission of essential hypertension in 6 patients who had received kidney transplants . . . [Full Text of this Article]




This article has been cited by other articles:


Home page
Cardiovasc ResHome page
T. Schluter, U. Zimmermann, C. Protzel, B. Miehe, K.-J. Klebingat, R. Rettig, and O. Grisk
Intrarenal artery superoxide is mainly NADPH oxidase-derived and modulates endothelium-dependent dilation in elderly patients
Cardiovasc Res, November 12, 2009; (2009) cvp346v2.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
A. Ziomber, A. Machnik, A. Dahlmann, P. Dietsch, F.-X. Beck, H. Wagner, K. F. Hilgers, F. C. Luft, K.-U. Eckardt, and J. Titze
Sodium-, potassium-, chloride-, and bicarbonate-related effects on blood pressure and electrolyte homeostasis in deoxycorticosterone acetate-treated rats
Am J Physiol Renal Physiol, December 1, 2008; 295(6): F1752 - F1763.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
T. M. Coffman and S. D. Crowley
Kidney in Hypertension: Guyton Redux
Hypertension, April 1, 2008; 51(4): 811 - 816.
[Full Text] [PDF]


Home page
HypertensionHome page
J. A. McCormick, C.-L. Yang, and D. H. Ellison
WNK Kinases and Renal Sodium Transport in Health and Disease: An Integrated View
Hypertension, March 1, 2008; 51(3): 588 - 596.
[Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
T. Schluter, R. Grimm, A. Steinbach, G. Lorenz, R. Rettig, and O. Grisk
Neonatal sympathectomy reduces NADPH oxidase activity and vascular resistance in spontaneously hypertensive rat kidneys
Am J Physiol Regulatory Integrative Comp Physiol, August 1, 2006; 291(2): R391 - R399.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
M. P. Blaustein, J. Zhang, L. Chen, and B. P. Hamilton
How does salt retention raise blood pressure?
Am J Physiol Regulatory Integrative Comp Physiol, March 1, 2006; 290(3): R514 - R523.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
A. H. Brantsma, S. J.L. Bakker, D. de Zeeuw, P. E. de Jong, R. T. Gansevoort, and for the PREVEND Study Group
Urinary Albumin Excretion as a Predictor of the Development of Hypertension in the General Population
J. Am. Soc. Nephrol., February 1, 2006; 17(2): 331 - 335.
[Abstract] [Full Text] [PDF]